These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33993612)

  • 1. A consequence of drug targeting of aminoacyl-tRNA synthetases in Mycobacteriumtuberculosis.
    Ndagi U; Kumalo HM; Mhlongo NN
    Chem Biol Drug Des; 2021 Sep; 98(3):421-434. PubMed ID: 33993612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases.
    Rybak MY; Balanda AO; Yatsyshyna AP; Kotey IM; Starosyla SA; Bdzhola VG; Lukash LL; Yarmoluk SM; Tukalo MA; Volynets GP
    Sci Rep; 2021 Mar; 11(1):7162. PubMed ID: 33785838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.
    Lv PC; Zhu HL
    Curr Med Chem; 2012; 19(21):3550-63. PubMed ID: 22680640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility and mode of binding of the Mycobacterium tuberculosis cysteinyl transferase mycothiol ligase to tRNA synthetase inhibitors.
    Gutierrez-Lugo MT; Bewley CA
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2480-3. PubMed ID: 21392992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essentiality Assessment of Cysteinyl and Lysyl-tRNA Synthetases of Mycobacterium smegmatis.
    Ravishankar S; Ambady A; Swetha RG; Anbarasu A; Ramaiah S; Sambandamurthy VK
    PLoS One; 2016; 11(1):e0147188. PubMed ID: 26794499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-targeted hit identification using pharmacophore screening.
    Volynets GP; Starosyla SA; Rybak MY; Bdzhola VG; Kovalenko OP; Vdovin VS; Yarmoluk SM; Tukalo MA
    J Comput Aided Mol Des; 2019 Nov; 33(11):955-964. PubMed ID: 31691918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review.
    Bouz G; Zitko J
    Bioorg Chem; 2021 May; 110():104806. PubMed ID: 33799176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenylating enzymes in Mycobacterium tuberculosis as drug targets.
    Duckworth BP; Nelson KM; Aldrich CC
    Curr Top Med Chem; 2012; 12(7):766-96. PubMed ID: 22283817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery.
    Pang L; Weeks SD; Van Aerschot A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of pyrimidine substituted aminoacyl-sulfamoyl nucleosides as potential inhibitors targeting class I aminoacyl-tRNA synthetases.
    Nautiyal M; De Graef S; Pang L; Gadakh B; Strelkov SV; Weeks SD; Van Aerschot A
    Eur J Med Chem; 2019 Jul; 173():154-166. PubMed ID: 30995568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico discovery of aminoacyl-tRNA synthetase inhibitors.
    Zhao Y; Meng Q; Bai L; Zhou H
    Int J Mol Sci; 2014 Jan; 15(1):1358-73. PubMed ID: 24447926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A continuous assay for monitoring the synthetic and proofreading activities of multiple aminoacyl-tRNA synthetases for high-throughput drug discovery.
    Grube CD; Roy H
    RNA Biol; 2018; 15(4-5):659-666. PubMed ID: 29168435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoacyl tRNA synthetases as malarial drug targets: a comparative bioinformatics study.
    Nyamai DW; Tastan Bishop Ö
    Malar J; 2019 Feb; 18(1):34. PubMed ID: 30728021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
    De Ruysscher D; Pang L; Mattelaer CA; Nautiyal M; De Graef S; Rozenski J; Strelkov SV; Lescrinier E; Weeks SD; Van Aerschot A
    Bioorg Med Chem; 2020 Aug; 28(15):115580. PubMed ID: 32631562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Multiple Aminoacyl-tRNA Synthetases Overcomes the Resistance Liabilities Associated with Antibacterial Inhibitors Acting on a Single Such Enzyme.
    Randall CP; Rasina D; Jirgensons A; O'Neill AJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6359-61. PubMed ID: 27431224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Search for inhibitors of aminoacyl-tRNA synthases by virtual click chemistry.
    Hoffmann M; Torchala M
    J Mol Model; 2009 Jun; 15(6):665-72. PubMed ID: 19048310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of aminoacyl-tRNA synthetases as novel anti-infectives.
    Tao J; Schimmel P
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1767-75. PubMed ID: 11060775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on targeting aminoacyl-tRNA synthetases for the treatment of fungal infections.
    Ferrer E
    Drug News Perspect; 2006; 19(6):347-8. PubMed ID: 16971970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.